KCK-based Cingulate hires a top legal officer as it enters the home stretch of its effort to win FDA approval for a new drug.

A neuroimaging study of adults treated for ADHD with psychostimulants reported that these individuals show increased surface ...

A neuroimaging study comparing individuals with insomnia to healthy adults found disrupted connectivity in the sensory ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain imaging ...

Available evidence suggests that dynamic functional connectivity can capture time-varying abnormalities in brain activity in resting-state cerebral functional magnetic resonance imaging (rs-fMRI) data ...

Dallas, Texas-- (Newsfile Corp. - June 18, 2025) - Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners initiates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate reported 1Q25 ...

View the latest Cingulate Inc. (CING) stock price, news, historical charts, analyst ratings and financial information from WSJ.

On Monday, Cingulate Inc., a pharmaceutical company based in Kansas City, Kansas, announced the approval of an amendment to increase the number of shares in its equity incentive plan. The company, ...

Neuroscientists already knew that the fusiform gyrus processes high-level visual information, but its role in distinguishing imagined images from reality was unknown.